Luca Juuhl
Medical · Orland Park, ILNPI 1841901261
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 355 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 15.9% — the pattern of someone who eats at a lot of different presentations. Among medical clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 355 payments — averaging $21.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Corium, LLC$804
- Axsome Therapeutics, Inc.$761
- Lundbeck LLC$552
- Otsuka America Pharmaceutical, Inc.$535
- Tris Pharma Inc$441
- plus $3K from 23 others
What the payments were for
- Food & beverage$7,545100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 64 | $1,198 |
| Corium, LLC | 32 | $804 |
| Axsome Therapeutics, Inc. | 25 | $761 |
| Lundbeck LLC | 28 | $552 |
| Otsuka America Pharmaceutical, Inc. | 29 | $535 |
| Tris Pharma Inc | 25 | $441 |
| Vanda Pharmaceuticals Inc. | 12 | $403 |
| Johnson & Johnson | 15 | $393 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 17 | $319 |
| Neurocrine Biosciences, Inc. | 12 | $319 |
| Idorsia Pharmaceuticals US Inc | 25 | $314 |
| Teva Pharmaceuticals USA, Inc. | 14 | $300 |
| Alkermes, Inc. | 13 | $248 |
| E.r. Squibb & Sons, L.L.C. | 7 | $163 |
| Supernus Pharmaceuticals, Inc. | 4 | $109 |
| Almatica Pharma LLC | 4 | $107 |
| Indivior Inc. | 4 | $103 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $85 |
| Noven Therapeutics, LLC | 4 | $80 |
| Ironshore Pharmaceuticals Inc. | 4 | $72 |
| Biogen | 2 | $47 |
| Orexo US, Inc. | 2 | $47 |
| USWM, LLC | 2 | $31 |
| Braeburn Inc. | 1 | $26 |
| Neos Therapeutics, LP | 1 | $20 |
| Livanova USA, Inc. | 1 | $19 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
| Bausch Health US, LLC | 1 | $17 |
| Abbott | 2 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auvelity$104
How this compares
$7,545 in reported general payments places this provider in the 90th percentile of 449 medical providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 12 | $24,961 |
| Lisdexamfetamine Dimesylate | 15 | $3,058 |
| Bupropion XlBupropion Hcl | 117 | $2,971 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 12 | $1,796 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 45 | $1,644 |
| Escitalopram Oxalate | 120 | $1,458 |
| Quetiapine Fumarate | 30 | $942 |
| Vilazodone Hcl | 14 | $897 |
| Trazodone Hcl | 107 | $894 |
| Duloxetine Hcl | 71 | $875 |
| Hydroxyzine Hcl | 44 | $867 |
| Lamotrigine | 44 | $708 |
| Naltrexone Hcl | 11 | $696 |
| Buspirone Hcl | 46 | $663 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 24 | $603 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $1,198 | $24,96112 claims |
| Almatica Pharma LLCSertraline Hcl | $107 | $49162 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 449 medical providers in Illinois.
Other medical in Orland Park
- Andrea TurekChicago$145K
- Priya BediElmhurst$56K
- Jennifer GarsonChicago$32K
- Bernice JohnsonPalos Heights$32K
- William KvasnickaChicago$19K
- Katie SpringerLake Forest$17K
- Matthew BrunoMorris$17K
- Kelly BrawleyBarrington$14K
- Megan GriggsSpringfield$13K
- Marianne RaoAlgonquin$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.